ZA88830B - Treatment of disease - Google Patents

Treatment of disease

Info

Publication number
ZA88830B
ZA88830B ZA88830A ZA88830A ZA88830B ZA 88830 B ZA88830 B ZA 88830B ZA 88830 A ZA88830 A ZA 88830A ZA 88830 A ZA88830 A ZA 88830A ZA 88830 B ZA88830 B ZA 88830B
Authority
ZA
South Africa
Prior art keywords
treatment
disease
rheumatoid arthritis
methylpyrido
dimethoxybenzyl
Prior art date
Application number
ZA88830A
Other languages
English (en)
Inventor
Carol Stella Schomber Charping
Stella Schomberg Charpin Carol
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of ZA88830B publication Critical patent/ZA88830B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA88830A 1987-02-06 1988-02-05 Treatment of disease ZA88830B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB878702758A GB8702758D0 (en) 1987-02-06 1987-02-06 Treatment of disease

Publications (1)

Publication Number Publication Date
ZA88830B true ZA88830B (en) 1989-10-25

Family

ID=10611861

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA88830A ZA88830B (en) 1987-02-06 1988-02-05 Treatment of disease

Country Status (11)

Country Link
US (1) US4818759A (OSRAM)
EP (1) EP0279565B1 (OSRAM)
JP (1) JP2527782B2 (OSRAM)
AT (1) ATE70977T1 (OSRAM)
AU (1) AU606128B2 (OSRAM)
CA (1) CA1302273C (OSRAM)
DE (1) DE3867251D1 (OSRAM)
ES (1) ES2039610T3 (OSRAM)
GB (1) GB8702758D0 (OSRAM)
GR (1) GR3003880T3 (OSRAM)
ZA (1) ZA88830B (OSRAM)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1229203B (it) * 1989-03-22 1991-07-25 Bioresearch Spa Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative.
PT100905A (pt) * 1991-09-30 1994-02-28 Eisai Co Ltd Compostos heterociclicos azotados biciclicos contendo aneis de benzeno, ciclo-hexano ou piridina e de pirimidina, piridina ou imidazol substituidos e composicoes farmaceuticas que os contem
MXPA03007166A (es) * 2001-02-12 2003-11-18 Hoffmann La Roche Pirido-pirimidinas 6-sustituidas.
EP1896035B1 (en) 2004-06-16 2014-10-15 Jack L. Arbiser Carbazole formulations for the treatment of psoriasis and angiogenesis

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3322765A (en) * 1963-10-30 1967-05-30 Burroughs Wellcome Co 2, 4-diamino-6-benzylpyrido-(2, 3-d) pyrimidines and method
ZA803539B (en) * 1979-06-14 1982-01-27 Wellcome Found Alkoxybenzylrimidines method for their preparation formulation thereof and their use in medicine
IT1146940B (it) * 1979-06-14 1986-11-19 Wellcome Found Composti 2,4-diamminopirido (2,3-d) pirimidinici dotati di attivita' farmacologica e procedimento per la loro preparazione
ZA861235B (en) * 1985-03-08 1986-10-29 Univ Princeton Pyrido(2,3-d)pyrimidine derivatives
EP0278686A1 (en) * 1987-02-07 1988-08-17 The Wellcome Foundation Limited Pyridopyrimidines methods for their preparation and pharmaceutical formulations thereof
SE9801992D0 (sv) * 1998-06-04 1998-06-04 Astra Ab New 3-aryl-2-hydroxypropionic acid derivative I

Also Published As

Publication number Publication date
GB8702758D0 (en) 1987-03-11
EP0279565A1 (en) 1988-08-24
AU606128B2 (en) 1991-01-31
CA1302273C (en) 1992-06-02
ES2039610T3 (es) 1993-10-01
JP2527782B2 (ja) 1996-08-28
GR3003880T3 (OSRAM) 1993-03-16
JPS63216884A (ja) 1988-09-09
EP0279565B1 (en) 1992-01-02
AU1135788A (en) 1988-08-11
US4818759A (en) 1989-04-04
DE3867251D1 (de) 1992-02-13
ATE70977T1 (de) 1992-01-15

Similar Documents

Publication Publication Date Title
EP0379806A3 (en) Pyrimidines and their pharmaceutical acceptable salts, and their use as medicines
EP0495982A4 (en) Bicyclic pyrimidine derivative, method of producing the same, and pharmaceutical preparation containing the same as active ingredient
GR3007251T3 (OSRAM)
MA22894A1 (fr) Procede de preparation d'un vaccin.
MA21682A1 (fr) Procede de preparation d'agents therapeutiques derives de la quainclidine.
ZA899028B (en) Compound for treatment for autoimmune diseases
AU8091787A (en) The use of paroxetine to treat pain
GR3004440T3 (OSRAM)
AU6006090A (en) A method of increasing adenosine excretion
DE3566404D1 (en) Substituted benzopyrans, process for their preparation and their use in medicines
ZA893086B (en) 4-quinoline carboxylic acid derivatives useful for treating skin and muco-epithelial disease
GB8702758D0 (en) Treatment of disease
MY104521A (en) Treatment of depression.
EP0500953A4 (en) Antineoplastic effect potentiator and antineoplastic agent
PT86032A (de) Ifosfamid-lyophilisat und verfahren zu dessen herstellung
ZA936300B (en) Use of L-carnitine and acyl L-carnitines for treating patients suffering from AIDS and AIDS-related syndromes and asymptomatic HIV-seropositive patients
FR2604707B1 (fr) Procede de preparation d'un compose therapeutique actif
IL85031A (en) Lyophilized aspoxicillin preparation and its manufacture
FR2624019B1 (fr) Preparation pour la regulation physiologique du systeme neuro-endocrinien, la stimulation de l'immunite, et l'inhibition de la croissance des tumeurs hormono-dependantes, et procede d'obtention de cette preparation.
HUT47384A (en) Insecticides and acaricides comprising pyrimidine derivatives as active ingredient and process for producing the active ingredient
CA2062094A1 (en) Method of treating mania